Centre plans to increase number of Janaushadhi Kendras to 10,000 by March 2024
Under PMBJP, an incentive of Rs 5 lakh is provided to the Janaushadhi Kendras as financial assistance.;
Advertisement
New Delhi: The government on Saturday said it plans to increase the number of generic drugs stores, the Pradhan Mantri Bhartiya Janaushadhi Kendras (PMBJKs) to 10,000 by March 2024 in order to accelerate the drive to make quality medicines available at affordable prices to all.
Around Rs, 18,000 crores have been saved through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) in the last eight years and the government has deepened the reach of the scheme with more than 9,000 stores covering 743 out of 766 districts across the country, an official statement said.
Medicines which are priced 50 percent to 90 percent less than that of branded versions are sold at the PMBJKs with the product basket comprising 1,759 medicines and 280 surgical devices covering all major therapeutic groups such as cardiovascular, anti-cancers, anti-diabetics, anti-infectives, anti-allergic, gastro-intestinal medicines and nutraceuticals, among others.
Launched by the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, in November 2008, PMBJP had achieved the target of opening 3,000 kendras in December 2017. Further, a revised target of 6,000 outlets was also achieved in March 2020.
Read also: Centre working on policy to encourage pharma sector research: Union Health Minister
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.